Skip to main content
Top
Published in: BMC Cancer 1/2012

Open Access 01-12-2012 | Research article

Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: A meta-analysis of clinical evidence

Authors: Francis CH Ho, Ivan WK Tham, Arul Earnest, Khai Mun Lee, Jiade J Lu

Published in: BMC Cancer | Issue 1/2012

Login to get access

Abstract

Background

The characteristics of cervical lymphatic metastasis in nasopharyngeal carcinoma (NPC) are not completely understood. As such, radiotherapy to the entire lymphatic of the neck bilaterally has been empirically practiced even in early stage disease, although not supported by clinical evidence. We studied the pattern and probability of nodal metastasis through a meta-analysis of published evidences, with an aim to establish an evidence-based guideline for selecting and delineation of clinical target volume of neck lymphatics for conformation radiation for NPC.

Methods

A literature search yielded an initial 411 original articles, and 13 studies with 2920 NPC cases staged via MRI were included in this analysis. The occurrence of nodal metastasis was calculated and analyzed according to the respective regional nodal levels.

Results

85% of NPC cases presented with lymphadenopathy. The most commonly involved regions include retropharyngeal (69%) and level II lymph nodes (70%). The overall probability of levels III, IV, and V nodal involvement are 45%, 11%, and 27%, respectively. Low-risk node groups included the supraclavicular, levels IA/IB and VI nodes, and parotid nodes with involvement rates at 3%, 0%, 3%, 0%, and 1%, respectively. Nodal metastases followed an orderly pattern and the probability of "skip" metastasis between levels varied between 0.5-7.9%.

Conclusions

Lymph node metastasis in NPC follows a predictable and orderly pattern. The rarity of metastasis in certain nodal groups and "skip" metastasis suggest that reduced treatment volume is feasible in conformal radiotherapy for NPC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parkin WS, Ferlay RL, Young J: Cancer Incidence in Five Continents, Vol 7. 1997, Lyon: IARC Press, 7: Parkin WS, Ferlay RL, Young J: Cancer Incidence in Five Continents, Vol 7. 1997, Lyon: IARC Press, 7:
2.
go back to reference Sham JS, Choy D, Wei WI: Nasopharyngeal carcinoma: orderly neck node spread. Int J Radiat Oncol Biol Phys. 1990, 19 (4): 929-933. 10.1016/0360-3016(90)90014-B.CrossRefPubMed Sham JS, Choy D, Wei WI: Nasopharyngeal carcinoma: orderly neck node spread. Int J Radiat Oncol Biol Phys. 1990, 19 (4): 929-933. 10.1016/0360-3016(90)90014-B.CrossRefPubMed
3.
go back to reference Lee AW, Sham JS, Poon YF, Ho JH: Treatment of stage I nasopharyngeal carcinoma: analysis of the patterns of relapse and the results of withholding elective neck irradiation. Int J Radiat Oncol Biol Phys. 1989, 17 (6): 1183-1190. 10.1016/0360-3016(89)90524-5.CrossRefPubMed Lee AW, Sham JS, Poon YF, Ho JH: Treatment of stage I nasopharyngeal carcinoma: analysis of the patterns of relapse and the results of withholding elective neck irradiation. Int J Radiat Oncol Biol Phys. 1989, 17 (6): 1183-1190. 10.1016/0360-3016(89)90524-5.CrossRefPubMed
4.
go back to reference CA P: Nasopharynx. Principles and Practice of Radiation Oncolog. 1998, Philadelphia: JB Lippincott, 3 CA P: Nasopharynx. Principles and Practice of Radiation Oncolog. 1998, Philadelphia: JB Lippincott, 3
5.
go back to reference Lee AW, Ng WT, Hung WM, Choi CW, Tung R, Ling YH, Cheng PT, Yau TK, Chang AT, Leung SK, et al: Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors. Int J Radiat Oncol Biol Phys. 2009, 73 (4): 1121-1128. 10.1016/j.ijrobp.2008.05.023.CrossRefPubMed Lee AW, Ng WT, Hung WM, Choi CW, Tung R, Ling YH, Cheng PT, Yau TK, Chang AT, Leung SK, et al: Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors. Int J Radiat Oncol Biol Phys. 2009, 73 (4): 1121-1128. 10.1016/j.ijrobp.2008.05.023.CrossRefPubMed
6.
go back to reference Liao XB, Mao YP, Liu LZ, Tang LL, Sun Y, Wang Y, Lin AH, Cui CY, Li L, Ma J: How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography?. Int J Radiat Oncol Biol Phys. 2008, 72 (5): 1368-1377. 10.1016/j.ijrobp.2008.03.017.CrossRefPubMed Liao XB, Mao YP, Liu LZ, Tang LL, Sun Y, Wang Y, Lin AH, Cui CY, Li L, Ma J: How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography?. Int J Radiat Oncol Biol Phys. 2008, 72 (5): 1368-1377. 10.1016/j.ijrobp.2008.03.017.CrossRefPubMed
7.
go back to reference King AD, Ahuja AT, Leung SF, Lam WW, Teo P, Chan YL, Metreweli C: Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck. 2000, 22 (3): 275-281. 10.1002/(SICI)1097-0347(200005)22:3<275::AID-HED10>3.0.CO;2-N.CrossRefPubMed King AD, Ahuja AT, Leung SF, Lam WW, Teo P, Chan YL, Metreweli C: Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck. 2000, 22 (3): 275-281. 10.1002/(SICI)1097-0347(200005)22:3<275::AID-HED10>3.0.CO;2-N.CrossRefPubMed
8.
go back to reference Ng SH, Chang TC, Ko SF, Yen PS, Wan YL, Tang LM, Tsai MH: Nasopharyngeal carcinoma: MRI and CT assessment. Neuroradiology. 1997, 39 (10): 741-746. 10.1007/s002340050499.CrossRefPubMed Ng SH, Chang TC, Ko SF, Yen PS, Wan YL, Tang LM, Tsai MH: Nasopharyngeal carcinoma: MRI and CT assessment. Neuroradiology. 1997, 39 (10): 741-746. 10.1007/s002340050499.CrossRefPubMed
9.
go back to reference Sakata K, Hareyama M, Tamakawa M, Oouchi A, Sido M, Nagakura H, Akiba H, Koito K, Himi T, Asakura K: Prognostic factors of nasopharynx tumors investigated by MR imaging and the value of MR imaging in the newly published TNM staging. Int J Radiat Oncol Biol Phys. 1999, 43 (2): 273-278. 10.1016/S0360-3016(98)00417-9.CrossRefPubMed Sakata K, Hareyama M, Tamakawa M, Oouchi A, Sido M, Nagakura H, Akiba H, Koito K, Himi T, Asakura K: Prognostic factors of nasopharynx tumors investigated by MR imaging and the value of MR imaging in the newly published TNM staging. Int J Radiat Oncol Biol Phys. 1999, 43 (2): 273-278. 10.1016/S0360-3016(98)00417-9.CrossRefPubMed
10.
go back to reference Garden AS: Where are the at-risk cervical nodes?. Int J Radiat Oncol Biol Phys. 2004, 58 (1): 1-2. 10.1016/S0360-3016(03)01451-2.CrossRefPubMed Garden AS: Where are the at-risk cervical nodes?. Int J Radiat Oncol Biol Phys. 2004, 58 (1): 1-2. 10.1016/S0360-3016(03)01451-2.CrossRefPubMed
11.
go back to reference Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, Chao C, Coche E, Cooper JS, Cosnard G, et al: CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003, 69 (3): 227-236. 10.1016/j.radonc.2003.09.011.CrossRefPubMed Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, Chao C, Coche E, Cooper JS, Cosnard G, et al: CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003, 69 (3): 227-236. 10.1016/j.radonc.2003.09.011.CrossRefPubMed
12.
go back to reference Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Yen TC: Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging. 2004, 31 (8): 1073-1080.CrossRefPubMed Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Yen TC: Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging. 2004, 31 (8): 1073-1080.CrossRefPubMed
13.
go back to reference Liu LZ, Zhang GY, Xie CM, Liu XW, Cui CY, Li L: Magnetic resonance imaging of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: patterns of spread. Int J Radiat Oncol Biol Phys. 2006, 66 (3): 721-730. 10.1016/j.ijrobp.2006.05.054.CrossRefPubMed Liu LZ, Zhang GY, Xie CM, Liu XW, Cui CY, Li L: Magnetic resonance imaging of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: patterns of spread. Int J Radiat Oncol Biol Phys. 2006, 66 (3): 721-730. 10.1016/j.ijrobp.2006.05.054.CrossRefPubMed
14.
go back to reference Tang L, Mao Y, Liu L, Liang S, Chen Y, Sun Y, Liao X, Lin A, Liu M, Li L, et al: The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging. Cancer. 2009, 115 (3): 680-688. 10.1002/cncr.24049.CrossRefPubMed Tang L, Mao Y, Liu L, Liang S, Chen Y, Sun Y, Liao X, Lin A, Liu M, Li L, et al: The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging. Cancer. 2009, 115 (3): 680-688. 10.1002/cncr.24049.CrossRefPubMed
15.
go back to reference Ng S-H, Chang J-C, Chan S-C, Ko S-F, Wang H-M, Liao C-T, Chang Y-C, Yen T-C: Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging. 2004, 31 (8): 1073-1080.CrossRefPubMed Ng S-H, Chang J-C, Chan S-C, Ko S-F, Wang H-M, Liao C-T, Chang Y-C, Yen T-C: Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging. 2004, 31 (8): 1073-1080.CrossRefPubMed
16.
go back to reference Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994, 50 (4): 1088-1101. 10.2307/2533446.CrossRefPubMed Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994, 50 (4): 1088-1101. 10.2307/2533446.CrossRefPubMed
17.
go back to reference Cochran WG, Cox GM: Experimental design. 1992, New York: Wiley, 2 Cochran WG, Cox GM: Experimental design. 1992, New York: Wiley, 2
18.
go back to reference DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7 (3): 177-188. 10.1016/0197-2456(86)90046-2.CrossRefPubMed DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7 (3): 177-188. 10.1016/0197-2456(86)90046-2.CrossRefPubMed
19.
go back to reference Wang X, Li L, Hu C, Zhou Z, Ying H, Ding J, Feng Y: Patterns of level II node metastasis in nasopharyngeal carcinoma. Radiother Oncol. 2008, 89 (1): 28-32. 10.1016/j.radonc.2008.07.014.CrossRefPubMed Wang X, Li L, Hu C, Zhou Z, Ying H, Ding J, Feng Y: Patterns of level II node metastasis in nasopharyngeal carcinoma. Radiother Oncol. 2008, 89 (1): 28-32. 10.1016/j.radonc.2008.07.014.CrossRefPubMed
20.
go back to reference Ng WT, Lee AW, Kan WK, Chan J, Pang ES, Yau TK, Lau KY: N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma: pattern of nodal involvement by radiological levels. Radiother Oncol. 2007, 82 (1): 70-75. 10.1016/j.radonc.2006.11.010.CrossRefPubMed Ng WT, Lee AW, Kan WK, Chan J, Pang ES, Yau TK, Lau KY: N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma: pattern of nodal involvement by radiological levels. Radiother Oncol. 2007, 82 (1): 70-75. 10.1016/j.radonc.2006.11.010.CrossRefPubMed
21.
go back to reference Fuwa N, Ariji Y, Daimon T, Wakisaka M, Matsumoto A, Kodaira T, Tachibana H, Nakamua T, Satou Y: Relationship between the growth pattern of nasopharyngeal cancer and the cervical lymph nodes based on MRI findings: can the cervical radiation field be reduced in patients with nasopharyngeal cancer?. Br J Radiol. 2006, 79 (945): 725-729. 10.1259/bjr/27870658.CrossRefPubMed Fuwa N, Ariji Y, Daimon T, Wakisaka M, Matsumoto A, Kodaira T, Tachibana H, Nakamua T, Satou Y: Relationship between the growth pattern of nasopharyngeal cancer and the cervical lymph nodes based on MRI findings: can the cervical radiation field be reduced in patients with nasopharyngeal cancer?. Br J Radiol. 2006, 79 (945): 725-729. 10.1259/bjr/27870658.CrossRefPubMed
22.
go back to reference Lu JC, Wei BQ, Chen WZ, Qian PD, Zhang YQ, Wei Q, Cha WW, Li F, Ni M: Staging of nasopharyngeal carcinoma investigated by magnetic resonance imaging. Radiother Oncol. 2006, 79 (1): 21-26. 10.1016/j.radonc.2006.03.015.CrossRefPubMed Lu JC, Wei BQ, Chen WZ, Qian PD, Zhang YQ, Wei Q, Cha WW, Li F, Ni M: Staging of nasopharyngeal carcinoma investigated by magnetic resonance imaging. Radiother Oncol. 2006, 79 (1): 21-26. 10.1016/j.radonc.2006.03.015.CrossRefPubMed
23.
go back to reference Lam WW, Chan YL, Leung SF, Metreweli C: Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Head Neck. 1997, 19 (3): 176-181. 10.1002/(SICI)1097-0347(199705)19:3<176::AID-HED2>3.0.CO;2-#.CrossRefPubMed Lam WW, Chan YL, Leung SF, Metreweli C: Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Head Neck. 1997, 19 (3): 176-181. 10.1002/(SICI)1097-0347(199705)19:3<176::AID-HED2>3.0.CO;2-#.CrossRefPubMed
24.
go back to reference Chong VF, Fan YF, Khoo JB: Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Eur J Radiol. 1995, 21 (2): 100-105. 10.1016/0720-048X(95)00689-N.CrossRefPubMed Chong VF, Fan YF, Khoo JB: Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Eur J Radiol. 1995, 21 (2): 100-105. 10.1016/0720-048X(95)00689-N.CrossRefPubMed
25.
go back to reference Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT: Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004, 60 (5): 1440-1450. 10.1016/j.ijrobp.2004.05.022.CrossRefPubMed Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT: Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004, 60 (5): 1440-1450. 10.1016/j.ijrobp.2004.05.022.CrossRefPubMed
26.
go back to reference Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ: Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006, 64 (1): 57-62. 10.1016/j.ijrobp.2005.03.057.CrossRefPubMed Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ: Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006, 64 (1): 57-62. 10.1016/j.ijrobp.2005.03.057.CrossRefPubMed
27.
go back to reference Som PM, Curtin HD, Mancuso AA: Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol. 2000, 174 (3): 837-844.CrossRefPubMed Som PM, Curtin HD, Mancuso AA: Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol. 2000, 174 (3): 837-844.CrossRefPubMed
28.
go back to reference Nasopharyngeal Cancer: Multidisciplinary Managemen. Edited by: Lu J, Cooper JS, Lee AWM. 2010, Berlin Heidelberg: Springer-Verlag Nasopharyngeal Cancer: Multidisciplinary Managemen. Edited by: Lu J, Cooper JS, Lee AWM. 2010, Berlin Heidelberg: Springer-Verlag
29.
go back to reference Lu J, Gregoire V, Lin S: Selection and Delineation of Target Volumes in Intensity-Modulated Radiation Therapy for Nasopharyngeal Cancer. Nasopharyngeal Cancer: Multidisciplinary Management. Edited by: Lu J, Cooper JS, Lee AWM. 2010, Berlin Heidelberg: Springer-Verlag, 213-232.CrossRef Lu J, Gregoire V, Lin S: Selection and Delineation of Target Volumes in Intensity-Modulated Radiation Therapy for Nasopharyngeal Cancer. Nasopharyngeal Cancer: Multidisciplinary Management. Edited by: Lu J, Cooper JS, Lee AWM. 2010, Berlin Heidelberg: Springer-Verlag, 213-232.CrossRef
30.
go back to reference Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, et al: Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009, 27 (22): 3684-3690. 10.1200/JCO.2008.19.9109.CrossRefPubMedPubMedCentral Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, et al: Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009, 27 (22): 3684-3690. 10.1200/JCO.2008.19.9109.CrossRefPubMedPubMedCentral
31.
go back to reference Ng WT, Lee MC, Hung WM, Choi CW, Lee KC, Chan OS, Lee AW: Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2011, 79 (2): 420-428. 10.1016/j.ijrobp.2009.11.024.CrossRefPubMed Ng WT, Lee MC, Hung WM, Choi CW, Lee KC, Chan OS, Lee AW: Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2011, 79 (2): 420-428. 10.1016/j.ijrobp.2009.11.024.CrossRefPubMed
32.
go back to reference Tham IW-K, Hee SW, Yeo RM-C, Salleh PB, Lee J, Tan TW-K, Fong KW, Chua ET, Wee JT-S: Treatment of Nasopharyngeal Carcinoma Using Intensity-Modulated Radiotherapy-The National Cancer Centre Singapore Experience. Int J Radiat Oncol Biol Phys. 2009, 75 (5): 1481-1486. 10.1016/j.ijrobp.2009.01.018.CrossRefPubMed Tham IW-K, Hee SW, Yeo RM-C, Salleh PB, Lee J, Tan TW-K, Fong KW, Chua ET, Wee JT-S: Treatment of Nasopharyngeal Carcinoma Using Intensity-Modulated Radiotherapy-The National Cancer Centre Singapore Experience. Int J Radiat Oncol Biol Phys. 2009, 75 (5): 1481-1486. 10.1016/j.ijrobp.2009.01.018.CrossRefPubMed
33.
go back to reference Lin S, Lu J, Han L, Chen Q, Pan J: Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases. BMC Cancer. 2010, 10 (1): 39-10.1186/1471-2407-10-39.CrossRefPubMedPubMedCentral Lin S, Lu J, Han L, Chen Q, Pan J: Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases. BMC Cancer. 2010, 10 (1): 39-10.1186/1471-2407-10-39.CrossRefPubMedPubMedCentral
34.
go back to reference Gao Y, Zhu G, Lu J, Ying H, Kong L, Wu Y, Hu C: Is Elective Irradiation to the Lower Neck Necessary for N0 Nasopharyngeal Carcinoma?. Int J Radiat Oncol Biol Phys. 2010, 77 (5): 1397-1402. 10.1016/j.ijrobp.2009.06.062.CrossRefPubMed Gao Y, Zhu G, Lu J, Ying H, Kong L, Wu Y, Hu C: Is Elective Irradiation to the Lower Neck Necessary for N0 Nasopharyngeal Carcinoma?. Int J Radiat Oncol Biol Phys. 2010, 77 (5): 1397-1402. 10.1016/j.ijrobp.2009.06.062.CrossRefPubMed
35.
go back to reference Castelijns J, van den Brekel M: Imaging of lymphadenopathy in the neck. Eur Radiol. 2002, 12 (4): 727-738. 10.1007/s003300101102.CrossRefPubMed Castelijns J, van den Brekel M: Imaging of lymphadenopathy in the neck. Eur Radiol. 2002, 12 (4): 727-738. 10.1007/s003300101102.CrossRefPubMed
36.
go back to reference TNM Classification of Malignant Tumour. Edited by: Sobin LHWC. 1997, New York: Wiley, 5 TNM Classification of Malignant Tumour. Edited by: Sobin LHWC. 1997, New York: Wiley, 5
37.
go back to reference Ng WT, Lee AWM, Kan WK, Chan J, Pang ESY, Yau TK, Lau KY: N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma: Pattern of nodal involvement by radiological levels. Radiother Oncol. 2007, 82 (1): 70-75. 10.1016/j.radonc.2006.11.010.CrossRefPubMed Ng WT, Lee AWM, Kan WK, Chan J, Pang ESY, Yau TK, Lau KY: N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma: Pattern of nodal involvement by radiological levels. Radiother Oncol. 2007, 82 (1): 70-75. 10.1016/j.radonc.2006.11.010.CrossRefPubMed
38.
go back to reference Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP: 18 F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008, 100 (10): 712-720. 10.1093/jnci/djn125.CrossRefPubMed Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP: 18 F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008, 100 (10): 712-720. 10.1093/jnci/djn125.CrossRefPubMed
39.
go back to reference TNM Classification of Malignant Tumour. Edited by: Sobin LH GM, Wittekind C. 2009, New York: Wiley, 7 TNM Classification of Malignant Tumour. Edited by: Sobin LH GM, Wittekind C. 2009, New York: Wiley, 7
40.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283 (15): 2008-2012. 10.1001/jama.283.15.2008.CrossRefPubMed Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283 (15): 2008-2012. 10.1001/jama.283.15.2008.CrossRefPubMed
41.
go back to reference Swartz MK: The PRISMA statement: a guideline for systematic reviews and meta-analyses. J Pediatr Health Care. 2011, 25 (1): 1-2. 10.1016/j.pedhc.2010.09.006.CrossRefPubMed Swartz MK: The PRISMA statement: a guideline for systematic reviews and meta-analyses. J Pediatr Health Care. 2011, 25 (1): 1-2. 10.1016/j.pedhc.2010.09.006.CrossRefPubMed
Metadata
Title
Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: A meta-analysis of clinical evidence
Authors
Francis CH Ho
Ivan WK Tham
Arul Earnest
Khai Mun Lee
Jiade J Lu
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2012
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-12-98

Other articles of this Issue 1/2012

BMC Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine